5-HT 1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo

Author： Broocks A.   Meyer T.   Opitz M.   Bartmann U.   Hillmer-Vogel U.   George A.   Pekrun G.   Wedekind D.   Ruther E.   Bandelow B.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.13, Iss.3, 2003-05, pp. : 153-164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder

By Dunbar G.   Judge R.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 361-362

Elsevier

Access to resources Recommend Favorite

A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder

By Sasson Y.   Iancu I.   Fux M.   Taub M.   Dannon P.N.   Zohar J.  

European Neuropsychopharmacology, Vol. 9, Iss. 3, 1999-03 ,pp. : 191-196

Elsevier

Access to resources Recommend Favorite

Tryptophan and Serotonin in Panic Disorder and Depression: Effect of Clomipramine Treatment

By Fekkes D.   Timmerman L.   Pepplinkhuizen L.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 286-287

Elsevier

Access to resources Recommend Favorite

Nocturnal Urinary Cortisol Excretion Over a Randomized Controlled Trial with Paroxetine vs. Placebo Combined with Relaxation Training or Aerobic Exercise in Panic Disorder

By  

Current Pharmaceutical Design, Vol. 14, Iss. 33, 2008-11 ,pp. : 3518-3524

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of clomipramine on plasma amino acids and serotonergic parameters in panic disorder and depression

By Fekkes D.   Timmerman L.   Pepplinkhuizen L.  

European Neuropsychopharmacology, Vol. 7, Iss. 3, 1997-08 ,pp. : 235-239

Elsevier

Access to resources Recommend Favorite